NEW YORK, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Wolf Popper LLP is investigating claims on behalf of investors in R1 RCM Inc. (NASDAQ:RCM) concerning the acquisition of R1 RCM by its significant shareholder, TowerBrook Capital Partners L.P. Under the terms of the acquisition, R1 RCM shareholders would receive $14.30 per share in cash. According to Wolf Popper partner Carl Stine, "The deal price of $14.30 per share seems unfairly low. It is significantly below R1 RCM's 52-week high stock price of $18.54 per shar ...

The SEED-Eisai Research Collaboration leverages Eisai's leading expertise in neurodegeneration and cancer. SEED is entitled to receive upfront and milestone payments of up to $1.5 billion plus tiered royalties upon Eisai's exercise of their exclusive rights under the strategic research collaboration Concurrently, SEED has launched Series A-3 financing with a first close of $24 million from investors led by Eisai. A second close is targeted for Q4 2024 The Series A-3 financing will advance clinical developme ...

Beamr Issues Q2-2024 CEO Letter to Shareholders and Announces its First Half 2024 Financial Results Herzliya, Israel, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Beamr Imaging Ltd. (NASDAQ: BMR), a leader in video optimization technology and solutions, today issued a Letter to Shareholders from Sharon Carmel, Chief Executive Officer, including its financial results for the six months ended June 30, 2024. Dear Shareholders: I am pleased to update you on our Q2-2024 activities and progress, which include significant de ...

Semi-Live Focal One Procedure to be Conducted on August 15th at 5:00 pm (KST) LYON, France, August 6, 2024 - EDAP TMS SA (NASDAQ:EDAP), the global leader in robotic energy-based therapies, today announced that the Company's leading robotic HIFU technology platform, Focal One, will be featured at the 41st World Congress of Endourology and Uro-Technology (WCET 2024) meeting, taking place in Seoul, South Korea, from August 12-16, 2024. "Our leading Focal One platform continues to generate strong interest from ...

PHILADELPHIA, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ:PASG), a clinicalstage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced that management will participate in the following upcoming investor conferences: Canaccord Genuity 44th Annual Growth Conference Format: Management will participate in a presentation and investor meetings Date: Tuesday, August 13, 2024 Presentation Time: 8:00 a.m. ET Location: Boston, MA 15th Ann ...

SAN FRANCISCO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Augmedix (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, announced today it anticipates releasing second quarter 2024 results after the market closes on Monday, August 12, 2024. On July 19, 2024, Augmedix announced that it entered into a definitive agreement to be acquired by Commure, Inc., a leading provider of technology to healthcare systems. Due to this pending acquisition, management is not hosting a quarterly conference c ...

PLANO, Texas, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Today, European Wax Center, Inc. (NASDAQ:EWCZ) (the "Company" or "European Wax Center"), the largest and fastest-growing franchisor and operator of out-of-home waxing services in the United States, announced the appointment of Julia Hunter to its Board of Directors ("Board"), effective August 1, 2024. Ms. Hunter will serve on the Nominating and Governance committee. Ms. Hunter joins the European Wax Center Board currently serving as the CEO of luxury Californi ...

LONDON and NEW YORK, Aug. 06, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease (DED), a multi-billion-dollar market, and anterior ocular segment diseases including neuropathic corneal pain (NCP), an ocular condition associated with pain but without an FDA approved therapy, announced today the grant of a key European Patent entitled: "Compositions Comprising Chemerin ...

Upon closing, Seres to receive $175M cash infusion, including an upfront payment, prepayment of a future commercial milestone payment, and an equity investment in Seres common stock, less approximately $20M in settlement of net obligations between the Parties; anticipated deal closing in the next 90 days Additional approximately $75M in cash payments are due to Seres in 2025, contingent upon Seres' compliance with transition obligations, with the potential for additional future commercial milestone payments ...

CONSHOHOCKEN, Pa., Aug. 6, 2024 /PRNewswire/ -- Leading private markets asset management firm Hamilton Lane Incorporated (Nasdaq: HLNE) today reported its results for the first fiscal quarter ended June 30, 2024. FIRST QUARTER FISCAL 2025 HIGHLIGHTS Assets under management – Total assets under management of $129.7 billion grew 11% year-over-year. Fee-earning assets under management increased 13% to $67.7 billion over the same period. Revenue – Management and advisory fees of $140.0 million for the quarter r ...